Simulations Plus Inc (SLP) 7.96 $SLP Simulations Plus

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 10:05 AM

Simulations Plus Inc (SLP) 7.96 $SLP

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
BusinessWire - 1 hr 35 mins ago
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Thursday, August 18, 2016, to shareholders of record as of Thursday, August 11, 2016.
SLP: 7.96 (-0.05)

Simulations Plus Releases ADMET Predictor(TM) Version 8.0
BusinessWire - 1 hr 35 mins ago
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.0 of its best-in-class ADMET Predictor(TM) molecular property prediction software.
SLP: 7.96 (-0.05)

Simulations Plus (SLP) in Focus: Stock Adds 5.9% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 7:35AM CDT
Simulations Plus, Inc. (SLP) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
SLP: 7.96 (-0.05), EXA: 14.41 (-0.19)

Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016
BusinessWire - Tue Jun 07, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2016, the period ended May 31, 2016 (3QFY16).
SLP: 7.96 (-0.05)

Simulations Plus to Present at LD Micro Invitational on June 7, 2016
BusinessWire - Thu Jun 02, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development, announced that Walt Woltosz, chief executive officer, will present at the 6th Annual LD Micro Invitational investor conference on Tuesday, June 7, 2016, at 11:30 a.m. PT. The conference will be held June 7-9, 2016, at the Luxe Sunset Bel Air Hotel in Los Angeles.
SLP: 7.96 (-0.05)

Simulations Plus (SLP): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:12AM CDT
Simulations Plus, Inc. (SLP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
SLP: 7.96 (-0.05)

Simulations Plus Releases DDDPlus Version 5.0
BusinessWire - Thu Apr 14, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 5.0 of its DDDPlus(TM) in vitro dissolution experiment simulation software.
SLP: 7.96 (-0.05)

Simulations Plus posts 2Q profit
Automated Insights - Wed Apr 13, 3:06PM CDT
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Wednesday reported fiscal second-quarter profit of $1.1 million.
SLP: 7.96 (-0.05)

Simulations Plus Reports Second Quarter FY2016 Financial Results
BusinessWire - Wed Apr 13, 3:01PM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its second quarter of fiscal year 2016, the period ended February 29, 2016 (2QFY16).
SLP: 7.96 (-0.05)

Simulations Plus Releases KIWI Version 1.5
BusinessWire - Tue Mar 15, 2:00PM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its Buffalo division (Cognigen Corporation) has released Version 1.5 of KIWI(TM), a private cloud-based platform to efficiently and consistently organize, process, evaluate, and communicate modeling and simulation results.
SLP: 7.96 (-0.05)

Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016
BusinessWire - Thu Mar 10, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2016, the period ended February 29, 2016 (2QFY16).
SLP: 7.96 (-0.05)

Simulations Plus (SLP): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 7:37AM CST
Simulations Plus is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
SLP: 7.96 (-0.05)

Shares of SLP Up 17.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 01, 5:21PM CST
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on December 29th, 2015 at $9.62. In approximately 1 month, Simulations Plus has returned 17.42% as of today's recent price of $11.29.
SLP: 7.96 (-0.05)

Simulations Plus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
BusinessWire - Tue Jan 26, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that Walt Woltosz, Chairman and Chief Executive Officer, will provide a company overview at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on Thursday, February 11, 2016, at 8:30 a.m. EST. The conference will be held at the Convene Conference Center at 730 Third Avenue in New York City. Simulations Plus management will be available during the day for one-on-one meetings.
SLP: 7.96 (-0.05)

Uptrend Call Working As Simulations Plus Stock Rises 17.6% (SLP)
Comtex SmarTrend(R) - Mon Jan 25, 12:02PM CST
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on December 29th, 2015 at $9.62. In approximately 4 weeks, Simulations Plus has returned 17.63% as of today's recent price of $11.31.
SLP: 7.96 (-0.05)

Simulations Plus Reports First Quarter FY2016 Financial Results
BusinessWire - Thu Jan 14, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its first quarter of fiscal year 2016, the period ended November 30, 2015 (1QFY16).
SLP: 7.96 (-0.05)

New Information Reveals Opportunity in Volatility - Featured Research on Simulations Plus, Olympic Steel, Unity Bancorp, and Shore Bancshares
ACCESSWIRE - Mon Jan 11, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Simulations Plus Inc. (NASDAQ: SLP), Olympic Steel Inc. (NASDAQ: ZEUS), Unity Bancorp Inc. (NASDAQ: UNTY) and Shore Bancshares Inc. (NASDAQ: SHBI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SLP: 7.96 (-0.05), SHBI: 11.66 (-0.10), ZEUS: 28.28 (-0.38), UNTY: 12.62 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...